logo
Crackers Recall As FDA Issues Warning To Consumers

Crackers Recall As FDA Issues Warning To Consumers

Newsweek20 hours ago
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A recall of crackers due to possible undeclared sesame has been issued the second-highest risk warning by the U.S. Food and Drug Administration (FDA).
Distinctive Foods LLC, based in Illinois, issued a voluntary recall on July 25 for a select lot of Frederik's by Meijer Artisan Baked Sea Salt flatbread crackers. The FDA later issued a Class II risk classification for the recall on August 12.
Newsweek contacted Distinctive Foods LLC for comment via the company's online contact form outside of regular working hours.
Stock image. Distinctive Foods LLC issued a voluntary recall on July 25 for a select lot of crackers due to possible undeclared sesame.
Stock image. Distinctive Foods LLC issued a voluntary recall on July 25 for a select lot of crackers due to possible undeclared sesame.Why It Matters
A Class II risk classification (one of three) refers to a situation in which the "use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote," according to the FDA.
Sesame is one of the nine major food allergens as set out in the Food Allergy Safety, Treatment, Education, and Research (FASTER) Act. The others are milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat and soybeans.
New regulations were introduced from January 1, 2023, stipulating that sesame had to be labelled as an allergen on packaged foods and dietary supplements.
Allergic reactions vary in severity from mild symptoms, such as hives and lip swelling, to life-threatening complications, such as anaphylaxis, that may include fatal respiratory problems.
Almost six percent of U.S. adults and children have a food allergy, according to the Centers for Disease Control and Prevention.
What To Know
The product impacted by the recall is the following:
Frederik's by Meijer artisan baked sea salt flatbread crackers - UPC code: 7 13733 00048 2 - Lot number: 5154-1 - best-by date: November 30, 2025.
The FDA said 1,790 packets were affected by the recall, and that they were distributed to Ohio, Wisconsin and Michigan.
There have been no reports that anyone has been taken ill following the consumption of the affected product.
What People Are Saying
The FDA says on its website: "To protect those with food allergies and other food hypersensitivities, the FDA enforces regulations requiring companies to list ingredients on packaged foods and beverages. For certain foods or substances that cause allergies or other hypersensitivity reactions, there are more specific labeling requirements."
It adds: "When problems are found, the FDA works with firms to recall products and provide public notification to immediately alert consumers."
Dr. Sebastian Lighvani, the director of New York Allergy & Asthma PLLC, previously told Newsweek: "Every three minutes in the United States, someone ends up in an emergency room because of an allergic reaction after accidental ingestion of food. So even when we try hard, these reactions are happening. And if you look at the incidence of anaphylaxis, it has skyrocketed in the last five, 10, 20 years. And in the U.S., there's like a 300 to 400 percent increase in the rates of anaphylaxis to foods."
What Happens Next
The recall is listed as ongoing, according to the FDA.
Consumers who have an allergy or sensitivity to sesame should not consume this product.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mother-of-seven secures place on midwifery course after returning to education
Mother-of-seven secures place on midwifery course after returning to education

Yahoo

time4 minutes ago

  • Yahoo

Mother-of-seven secures place on midwifery course after returning to education

A mother-of-seven who returned to education after jobs in hairdressing and floristry has secured a place on a midwifery course at university. Emily Porter, 38, of Mildenhall, Suffolk, said she never thought she was 'clever enough to be a midwife'. But she said she always told her children that 'as long as you set your mind to something, you can be anything you want to be', and decided to follow her own advice. She has now secured a place to study a three-year midwifery degree at the University of Suffolk, having been to college and completed qualifications. Ms Porter, whose children are aged between two and 16, completed four functional skills qualifications and a health-related access course. She did this at the West Suffolk College learning centre in Thetford, Norfolk and at Eastern and Education Group's University and Professional Development Centre in Bury St Edmunds, Suffolk. 'I never thought I was clever enough to be a midwife,' said Ms Porter. 'But I always say to my kids that as long as you set your mind to something, you can be anything you want to be. 'Pilots and doctors are human just like you. 'But then I wasn't following the advice I was giving to them. 'So I decided to go back to college and give it everything I've got. 'I was looking after my seven children, working in a pub a couple of nights a week and studying between 4am and 7am, before the kids got up, and at weekends. 'It was a struggle but I kept at it. I never quit.' She said her message to others is 'you can always find a way – you just need to look for it'. 'I've always been so insecure in my ability in education,' said Ms Porter. 'But when you want something so bad you go above and beyond. 'I'm lucky to have such a good support network. I have so many cheerleaders in my corner. 'I'm blown away (by the prospect of going to university). 'I might have a bit of imposter syndrome at the start, but once I'm in there, the only way is up and the only thing to do is complete the degree. 'I sometimes sit there and think about graduating. It makes me emotional.' She said she left school with grades 'that weren't very good' but decided, just after the Covid-19 pandemic, that she wanted 'to do something that means something and makes a difference'. She had an interest in becoming a midwife and researched how she could achieve this. She said the college support was 'amazing', adding: 'They have gone out of their way to help me and you are set up not to fail. 'Now I think that I can take the world on.' Ian Evans, head of personal and professional learning at the West Suffolk College centre in Thetford, said: 'Emily has been a superb student who is a total inspiration. 'We are thrilled to have been able to support her as she follows her dreams of becoming a midwife.'

Another State Looks To Ban Junk Food From SNAP Benefits
Another State Looks To Ban Junk Food From SNAP Benefits

Newsweek

time6 minutes ago

  • Newsweek

Another State Looks To Ban Junk Food From SNAP Benefits

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Mississippi Governor Tate Reeves has said his state may block the purchase of unhealthy foods using SNAP benefits. Newsweek has contacted Reeves' office for comment via email outside regular working hours. Why It Matters So far in 2025, a slew of states have either barred or are in the process of restricting what Supplemental Nutrition Assistance Program (SNAP) beneficiaries can buy using their benefits. Advocates for restricting SNAP purchases argue that cutting unhealthy foods from the program will improve public health, with the Make America Healthy Again (MAHA) movement leading the charge. Opponents counter that such limits dictate the diets of low-income Americans while overlooking deeper problems related to accessing affordable, nutritious food. According to the Center on Budget and Policy Priorities, in Mississippi, some 384,800 people collect SNAP benefits, representing 13 percent of the state's population. What To Know Reeves, a Republican, said of restricting SNAP benefits, "It is on my radar," SuperTalk Mississippi Media reported on Wednesday. According to the outlet, he also discussed the idea with Health and Human Services Secretary Secretary Robert F. Kennedy Jr., who has spearheaded the MAHA movement, at the National Governors Association summer meeting. "I spent some time with my fellow governors a week or two ago," Reeves said. "We also had meetings with Secretary Kennedy while we were at the conference, very productive meetings, and that is something we are looking into." Republican Governor Tate Reeves speaks with supporters during an election night watch party at the Refuge Hotel & Conference Center in Flowood, Mississippi, on November 7, 2023. Republican Governor Tate Reeves speaks with supporters during an election night watch party at the Refuge Hotel & Conference Center in Flowood, Mississippi, on November 7, 2023. Brandon Bell/GETTY SNAP Changes Across the U.S. So far this year, 12 states have approved plans to restrict SNAP benefits. While the program is administered by states, it is overseen and largely paid for by the U.S. Department of Agriculture (USDA). To make amendments to SNAP, states are required to send waiver requests to the federal agency for approval. Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Louisiana, Nebraska, Oklahoma, Texas, Utah and West Virginia have all had their waiver requests approved. Tennessee and South Carolina have indicated that they are in the process of making similar requests to the USDA. Beginning in 2026, the approved waivers are set to prohibit certain foods from being purchased with electronic benefit transfer cards, which are reloaded monthly for use at participating grocery stores nationwide. Not all the new restrictions are the same. For example, in Colorado, Utah and West Virginia, only soft drinks and/or soda would no longer be purchasable with SNAP. In numerous other states, the restriction also extends to candy. What People Are Saying USDA Secretary Brooke Rollins said in an August 4 news release regarding states with approved waivers: "It is incredible to see so many states take action at this critical moment in our nation's history and do something to begin to address chronic health problems. President Trump has changed the status quo, and the entire cabinet is taking action to Make America Healthy Again. At USDA, we play a key role in supporting Americans who fall on hard times, and that commitment does not change. Rather, these state waivers promote healthier options for families in need." Health and Human Services Secretary Robert F. Kennedy Jr. said in the news release: "For years, SNAP has used taxpayer dollars to fund soda and candy—products that fuel America's diabetes and chronic disease epidemics. These waivers help put real food back at the center of the program and empower states to lead the charge in protecting public health. I thank these governors who have stepped up to request waivers, and I encourage others to follow their lead. This is how we Make America Healthy Again." Valerie Imbruce, the director of the Center for Environment and Society at Washington College, previously told Newsweek: "Controlling how the poor eat is a paternalistic response to a problem that is not based in SNAP recipients' inability to make good decisions about healthy foods, it is a problem of the price differential in choosing healthy or junk foods. Soda and candy are much cheaper and more calorie dense than 100 percent fruit juices or prebiotic non-artificially sweetened carbonated beverages, thanks to price supports and subsidies by the federal government to support a U.S. sugar industry." What Happens Next Reeves' comments suggest that Mississippi has not formally requested a waiver from the USDA. It remains to be seen whether the state will do so.

Implantica publishes Interim Report January - June 2025 (Q2)
Implantica publishes Interim Report January - June 2025 (Q2)

Yahoo

time2 hours ago

  • Yahoo

Implantica publishes Interim Report January - June 2025 (Q2)

VADUZ, Liechtenstein, Aug. 14, 2025 /PRNewswire/ -- Transforming Clinical Excellence of RefluxStop® into Strategic Market Momentum Significant events in the second quarter of 2025 FDA PMA Submission Completed - Submitted third and final module of the U.S. FDA pre-market approval (PMA) application for RefluxStop®, including responses to questions on the second module; Feedback on module 3 expected in the near-term Produced and completed initial testing on new multi-cavity production tool for RefluxStop® to support launch of manufacturing in U.S. and manage ramp-up of U.S. production (pending FDA approval) Additional preparations for U.S. market launch (pending FDA approval) included U.S. payer and reimbursement activities, finalizing new production facility of RefluxStop® in U.S. and launching our RCT (randomized clinical trial), as a heavyweight cornerstone in building global leadership in acid reflux care Positive NICE Guidance in the UK - UK's National Institute for Health and Care Excellence (NICE) issued positive guidance for the use of RefluxStop® in NHS hospitals for patients with ineffective esophageal motility (IOM/IEM), potentially transforming treatment access for millions and influencing global policy Significant events after the end of the period Landmark 5-Year Clinical Study Results - Two peer-reviewed articles were published in Surgical Endoscopy on our pivotal study results; one publication confirmed outstanding long-term safety and effectiveness outcomes, and the second publication highlighted RefluxStop®'s excellent outcomes in food passageway-related sequelae, which is common in standard of care Randomized Clinical Trial (RCT) Launch - First RCT comparing RefluxStop® with Nissen fundoplication; patient recruitment underway accumulating patients across participating hospitals. While this trial preparation led to a 20% year-on-year revenue decline for Q2, the impact is expected to ease once study recruitment stabilizes Spanish Market Expansion - Three new hospitals added, totaling 19 centers offering RefluxStop® in Spain, with a healthcare sytem receptive for new and better patient care, which is a fantastic launch since 2023 First UK National Users Meeting - Convened 21 top anti-reflux experts to discuss real-world results, operating technique and the opportunities arising from NICE's positive recommendation Financial summary second quarter 2025 Net sales decreased 22% to TEUR 433 (554) due to the launch of the randomized clinical trial with surgeons accumulating patients for the trial. Adjusted gross margin amounted to 90% (91%). Operating loss (EBIT) decreased to TEUR 4,525 (5,869). Loss after tax decreased to TEUR 5,448 (6,431). Basic and diluted loss per Class A share amounted to EUR 0.08 (0.09). Cash and short-term investments as at the end of the period of MEUR 56.3. First six months Net sales increased 2% to TEUR 1,178 (1,150). Adjusted gross margin amounted to 94% (91%). Operating loss (EBIT) decreased to TEUR 8,698 (12,956). Loss after tax decreased to TEUR 8,212 (9,903). Basic and diluted loss per Class A share amounted to EUR 0.12 (0.14). Telephone conference Implantica will hold a teleconference on 14 August 2025 at 15:00 (CEST) with Peter Forsell (CEO), Andreas Öhrnberg (CFO), and Nicole Pehrsson (Chief Corporate Affairs Officer). Please see the dial-in details below to join the conference: Webcast If you wish to participate via webcast, please use the following link: Dial-in Dial-in numbers to the teleconference will be received by registering on the link below. After the registration, you will be provided phone numbers and a conference ID to access the conference. For further information, please contact:Nicole Pehrsson, Chief Corporate Affairs OfficerTelephone (CH): +41 (0)79 335 09 Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm. The company's Certified Adviser is FNCA Sweden AB, info@ This information is information that Implantica AG is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-08-14 08:00 CEST. About Implantica: Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop®, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit for further information. This information was brought to you by Cision The following files are available for download: Implantica Q2 2025_ENG Implantica publishes Interim Report Jan - Jun 2025 Q2 View original content:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store